MC2418A1 - Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant - Google Patents

Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant

Info

Publication number
MC2418A1
MC2418A1 MC2347A MC2347A MC2418A1 MC 2418 A1 MC2418 A1 MC 2418A1 MC 2347 A MC2347 A MC 2347A MC 2347 A MC2347 A MC 2347A MC 2418 A1 MC2418 A1 MC 2418A1
Authority
MC
Monaco
Prior art keywords
piperazine
phenoxy
pyridyl
methyl
preparation
Prior art date
Application number
MC2347A
Other languages
English (en)
French (fr)
Inventor
Stuart Dennett Mills
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of MC2418A1 publication Critical patent/MC2418A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC2347A 1995-06-01 1996-05-29 Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant MC2418A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
MC2418A1 true MC2418A1 (fr) 1997-05-23

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
MC2347A MC2418A1 (fr) 1995-06-01 1996-05-29 Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant

Country Status (31)

Country Link
EP (1) EP0796247A1 (no)
JP (1) JP2885941B2 (no)
KR (1) KR100245957B1 (no)
AT (1) AT406675B (no)
AU (1) AU710105B2 (no)
BE (1) BE1009520A5 (no)
BR (1) BR9606409A (no)
CA (1) CA2194397A1 (no)
CH (1) CH691808A5 (no)
CZ (1) CZ26997A3 (no)
DE (1) DE19680509T1 (no)
DK (1) DK10697A (no)
ES (1) ES2137886B1 (no)
FI (1) FI970393A0 (no)
GB (1) GB2304340B (no)
GR (1) GR1002702B (no)
HU (1) HUP9700274A3 (no)
IE (1) IE960405A1 (no)
IL (1) IL118477A0 (no)
IT (1) IT1290839B1 (no)
LU (1) LU90008B1 (no)
MC (1) MC2418A1 (no)
MX (1) MX9700379A (no)
NL (1) NL1003243C2 (no)
NO (1) NO307460B1 (no)
NZ (1) NZ308597A (no)
PL (1) PL318440A1 (no)
SE (1) SE510812C2 (no)
SK (1) SK13097A3 (no)
TR (1) TR199700020T1 (no)
WO (1) WO1996038416A1 (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
PL310889A1 (en) * 1993-03-29 1996-01-08 Zeneca Ltd Heterocyclic derivatives as inhibitors of thrombocytes aggregation
NZ262942A (en) * 1993-03-29 1997-07-27 Zeneca Ltd Pyridyl substituted piperazine and various other derivatives of azaheteroaryl substituted piperazines; pharmaceutical compositions

Also Published As

Publication number Publication date
IL118477A0 (en) 1996-09-12
AT406675B (de) 2000-07-25
FI970393A (fi) 1997-01-30
ATA900596A (de) 1999-12-15
ES2137886A1 (es) 1999-12-16
HU9700274D0 (en) 1997-04-28
JP2885941B2 (ja) 1999-04-26
DE19680509T1 (de) 1997-12-04
KR970704689A (ko) 1997-09-06
SK13097A3 (en) 1997-08-06
ES2137886B1 (es) 2000-08-16
TR199700020T1 (tr) 1997-04-22
ITMI961113A0 (it) 1996-05-31
FI970393A0 (fi) 1997-01-30
LU90008B1 (fr) 1997-04-16
DK10697A (da) 1997-04-01
NO970437D0 (no) 1997-01-31
PL318440A1 (en) 1997-06-09
CA2194397A1 (en) 1996-12-05
NL1003243C2 (nl) 1996-12-04
ITMI961113A1 (it) 1997-12-01
CH691808A5 (de) 2001-10-31
SE9700203L (sv) 1997-01-24
MX9700379A (es) 1997-04-30
HUP9700274A3 (en) 2000-02-28
CZ26997A3 (en) 1997-08-13
KR100245957B1 (ko) 2000-04-01
HUP9700274A2 (hu) 1999-06-28
AU5827296A (en) 1996-12-18
GB9627127D0 (en) 1997-02-19
SE510812C2 (sv) 1999-06-28
BR9606409A (pt) 1997-09-30
IT1290839B1 (it) 1998-12-14
JPH09512836A (ja) 1997-12-22
NO970437L (no) 1997-02-20
SE9700203D0 (sv) 1997-01-24
WO1996038416A1 (en) 1996-12-05
GR1002702B (el) 1997-05-22
NZ308597A (en) 1998-11-25
IE960405A1 (en) 1996-12-11
EP0796247A1 (en) 1997-09-24
NO307460B1 (no) 2000-04-10
GB2304340A (en) 1997-03-19
AU710105B2 (en) 1999-09-16
GB2304340B (en) 1998-07-29
BE1009520A5 (fr) 1997-04-01

Similar Documents

Publication Publication Date Title
DZ2666A1 (fr) Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2538A1 (fr) Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant.
MA21749A1 (fr) Procede de compositions de deodorant contenant certains sels d'acide piroctonique et des parfums.
FR2526660B1 (fr) Procede de traitement thermique d'une fraction de plasma, produit obtenu et composition pharmaceutique le contenant
DZ2410A1 (fr) Dérivés d'acide arylsulfonylaminohydroxamique procédé pour leur préparation et compositions pharmaceutiques
DZ2679A1 (fr) Forme hydratée nouvelle d'un dérivé de thiazolidinedione procédé pour sa préparation et composition pharmaceutique la contenant.
MA23834A1 (fr) Procede de preparation de composes inhibiteurs de l'enzyme lp-pla2 et de compositions pharmaceutiques les contenant
HUP9603237A3 (en) Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them
AU5778090A (en) 11B-aryl-4-estrenes, process for their preparation as well as their use as pharmaceutical agents
MX9804226A (es) Derivados novedosos de 2,3,5-trimetil-4-hidroxianilida, su preparacion y su aplicacion de terapeutica.
DZ2680A1 (fr) Dérivé de thiazolidinedione nouveau procédé pour sa préparation et composition pharmaceutique le contenant.
HU912486D0 (en) Process for producing ethers and thioethers of piperidyl
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
PT86635A (pt) Process for the preparation of novel 4-aryl-n-]2-(dialkylamino and heterocyclicamino)-alkyl"-1-piperazinecarboxamides and of pharmaceutical compositions containing the same
TNSN97125A1 (fr) Composes furanne-nitrone
IT8722544A0 (it) Eparan solfato caratterizzato da elevata attivita' antitrombotica elevata biodisponibilita' assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche
MC2418A1 (fr) Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant
FR2739292B1 (fr) Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
BE1002239A5 (fr) Solution pharmaceutique.
FI884611A (fi) Menetelmä -/4-(1,1-dimetyylietyyli)fenyyli/-4-(hydroksidifenyylimetyyli)-1-piperidiinibutanolin farmaseuttisen koostumuksen valmistamiseksi
GEP20022794B (en) E-2-[4-(4-Chloro-1,2-Diphenyl-But-1-Enyl)Phenoxy]Ethanol And Pharmaceutical Compositions Thereof
FR2730163B1 (fr) Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation
MA22051A1 (fr) Procede d'obtention d'une formulation pharmaceutique
IL84521A0 (en) Salts of(3s(z))-2-(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)-amino)-2-oxoethylidene)-amino)oxy)acetic acid,process for the preparation thereof and pharmaceutical compositions containing the same
FR2761679B1 (fr) Procede pour l'elimination d'acides sulfureux residuaires de traitement industriel et pour l'obtention de produits stables